Monopar Therapeutics 13F holders
95 funds reported a position in Monopar Therapeutics in their 13F for the quarter ended 30 June 2026, together 6.2 million shares worth $576.1 million. Against the quarter before, 27 opened a position, 31 added, 24 trimmed and 14 sold out; together they sold a net 9,009 shares. The largest holders: Jupiter Topco LLC, Ra Capital Management, L.P. and BlackRock, Inc.
What each fund did in MNPR against its 13F for the quarter before; a change under 0.1% of a holding counts as held
Funds reporting a position in MNPR in their 13F, each quarter; hover a bar for the shares they held
Filed so far for the quarter to 30 September 2026
3,241 funds have filed their 13F for the quarter so far; the rest are due by 16 November 2026. Of those, 9 reported a position in Monopar Therapeutics: 5 opened one, 2 added, 0 trimmed and 0 sold out, a net 75 shares bought.
| Fund | Change in shares | Shares now | Status | Filing |
|---|---|---|---|---|
| Sterling Capital Management LLC | +32 | 104 | added | 13F |
| Gamma Investing LLC | +14 | 39 | added | 13F |
| Parkside Financial Bank & Trust | +13 | 13 | new | 13F |
| SJS Investment Consulting Inc. | +6 | 6 | new | 13F |
| Fortitude Family Office, LLC | +5 | 5 | new | 13F |
| MassMutual Private Wealth & Trust, FSB | +3 | 3 | new | 13F |
| Caitong International Asset Management Co., Ltd | +2 | 2 | new | 13F |
The largest moves in the name among the funds that have filed, against each fund's previous 13F.
The well-known funds
Of the 44 funds followed here, 6 reported a position in Monopar Therapeutics in a 13F for the quarter ended 30 June 2026. The largest: Geode Capital Management, 112,578 shares worth $10.4 million, 0.0% of its reported book. In the quarter, 3 funds added or opened a position and 2 trimmed or sold out; together they sold a net 8,804 shares, about $815,162 at the funds' own value per share on 30 June 2026. A change under 0.1% of a holding counts as held.
| Fund | Shares | Value | Of its book | Change on the quarter | Status | Quarter ended | Filing |
|---|---|---|---|---|---|---|---|
| Geode Capital Management | 112,578 | $10.4 million | 0.0% | +12,660 | added | 30 June 2026 | 13F |
| Alyeska | 100,000 | $9.3 million | 0.0% | no change | held | 30 June 2026 | 13F |
| Millennium Management | 50,311 | $4.7 million | 0.0% | -2,640 | trimmed | 30 June 2026 | 13F |
| Citadel Advisors | 37,004 | $3.4 million | 0.0% | -21,432 | trimmed | 30 June 2026 | 13F |
| Two Sigma Investments | 12,252 | $1.1 million | 0.0% | +2,487 | added | 30 June 2026 | 13F |
| FMR LLC | 530 | $49,073 | 0.0% | +121 | added | 30 June 2026 | 13F |
Read more
Change is shares against the fund's previous 13F; a fund with one filing read shows no change. 13Fs cover long US positions of managers above $100 million and are filed up to 45 days after the quarter.The largest holders
| Fund | Shares | Share of all | Value | Of its book | Change in shares | Filing |
|---|---|---|---|---|---|---|
| Jupiter Topco LLC | 1,312,129 | 21.09% | $121.7 million | 0.05% | first 13F | 13F |
| Ra Capital Management, L.P. | 667,207 | 10.72% | $61.8 million | 0.54% | no change | 13F |
| BlackRock, Inc. | 348,819 | 5.61% | $32.3 million | 0.00% | +32,252 | 13F |
| Deerfield Management Company, L.P. | 323,745 | 5.20% | $30.0 million | 0.37% | no change | 13F |
| Saturn V Capital Management LP | 311,976 | 5.01% | $28.9 million | 4.14% | -33,650 | 13F |
| Siren, L.L.C. | 270,118 | 4.34% | $25.0 million | 0.51% | no change | 13F |
| ADAR1 Capital Management, LLC | 217,595 | 3.50% | $20.1 million | 0.95% | -46,683 | 13F |
| Polar Capital Holdings Plc | 214,469 | 3.45% | $19.9 million | 0.06% | -12,057 | 13F |
| Vanguard Capital Management LLC | 209,711 | 3.37% | $19.4 million | 0.00% | -8,752 | 13F |
| Adage Capital Partners GP, L.l.c. | 209,195 | 3.36% | $19.4 million | 0.03% | -100,000 | 13F |
| TCG Crossover Management, LLC | 203,327 | 3.27% | $18.8 million | 0.45% | +71,224 | 13F |
| Wellington Management Group LLP | 158,437 | 2.55% | $14.7 million | 0.00% | -15,905 | 13F |
| Orbimed Advisors LLC | 157,423 | 2.53% | $14.6 million | 0.28% | new | 13F |
| Candriam S.C.A. | 143,339 | 2.30% | $13.3 million | 0.06% | new | 13F |
| Balyasny Asset Management L.P. | 134,543 | 2.16% | $12.5 million | 0.02% | -1,900 | 13F |
| Geode Capital Management, LLC | 112,578 | 1.81% | $10.4 million | 0.00% | +12,660 | 13F |
| Alyeska Investment Group, L.P. | 100,000 | 1.61% | $9.3 million | 0.02% | no change | 13F |
| State Street Corp. | 92,551 | 1.49% | $8.6 million | 0.00% | +4,196 | 13F |
| Vivo Capital, LLC | 90,500 | 1.45% | $8.4 million | 0.77% | no change | 13F |
| Driehaus Capital Management LLC | 84,040 | 1.35% | $7.8 million | 0.04% | +50,884 | 13F |
| Bank of New York Mellon Corp | 76,942 | 1.24% | $7.1 million | 0.00% | -1,676 | 13F |
| Vestal Point Capital, LP | 75,727 | 1.22% | $7.0 million | 0.16% | +10,309 | 13F |
| Longaeva Partners L.P. | 55,834 | 0.90% | $5.2 million | 0.15% | new | 13F |
| Neuberger Berman Group LLC | 55,194 | 0.89% | $5.1 million | 0.00% | +12,760 | 13F |
| Millennium Management LLC | 50,311 | 0.81% | $4.7 million | 0.00% | -2,640 | 13F |
| Vanguard Portfolio Management LLC | 48,816 | 0.78% | $4.5 million | 0.00% | +2,829 | 13F |
| Ikarian Capital, LLC | 47,861 | 0.77% | $4.4 million | 0.72% | new | 13F |
| Citadel Advisors LLC | 37,004 | 0.59% | $3.4 million | 0.00% | -21,432 | 13F |
| Northern Trust Corp. | 34,641 | 0.56% | $3.2 million | 0.00% | +2,779 | 13F |
| Deutsche Bank AG | 31,008 | 0.50% | $2.9 million | 0.00% | +2,186 | 13F |
| Stempoint Capital LP | 30,125 | 0.48% | $2.8 million | 0.48% | new | 13F |
| Vanguard Fiduciary Trust Co. | 28,280 | 0.45% | $2.6 million | 0.00% | -167 | 13F |
| UBS Group AG | 27,259 | 0.44% | $2.5 million | 0.00% | -12,177 | 13F |
| Morgan Stanley | 17,919 | 0.29% | $1.7 million | 0.00% | -4,393 | 13F |
| Ameriprise Financial Inc. | 17,800 | 0.29% | $1.6 million | 0.00% | +10,981 | 13F |
| Goldman Sachs Group Inc. | 16,161 | 0.26% | $1.5 million | 0.00% | -18,549 | 13F |
| Russell Investments Group, Ltd. | 14,850 | 0.24% | $1.4 million | 0.00% | +601 | 13F |
| Boothbay Fund Management, LLC | 14,689 | 0.24% | $1.4 million | 0.03% | new | 13F |
| Charles Schwab Investment Management Inc. | 13,953 | 0.22% | $1.3 million | 0.00% | +1,395 | 13F |
| Ishara Investments LP | 12,300 | 0.20% | $1.1 million | 0.84% | new | 13F |
| Two Sigma Investments, LP | 12,252 | 0.20% | $1.1 million | 0.00% | +2,487 | 13F |
| Trexquant Investment LP | 12,004 | 0.19% | $1.1 million | 0.01% | new | 13F |
| Creative Planning | 7,768 | 0.12% | $719,239 | 0.00% | +1,781 | 13F |
| Gsa Capital Partners LLP | 7,532 | 0.12% | $697,000 | 0.04% | new | 13F |
| XTX Topco Ltd | 6,536 | 0.11% | $605,168 | 0.01% | new | 13F |
| Nuveen, LLC | 5,980 | 0.10% | $553,688 | 0.00% | +429 | 13F |
| Barclays PLC | 5,833 | 0.09% | $540,077 | 0.00% | -19,102 | 13F |
| Rhumbline Advisers | 5,630 | 0.09% | $521,271 | 0.00% | +684 | 13F |
| Gerber, LLC | 5,601 | 0.09% | $518,597 | 0.24% | no change | 13F |
| Raymond James Financial Inc. | 5,474 | 0.09% | $506,838 | 0.00% | new | 13F |
Read more
Share of all is the fund's part of all the shares the funds reported. Change is shares against the fund's 13F for the quarter before. A 13F lists a manager's long positions in US-listed shares at the quarter's end. What is a 13F?Schedule 13D and 13G filed on the name, last twelve months
| Filed | Schedule | Who | Holding | Of the class | Event date | Rule or purpose | Filing |
|---|---|---|---|---|---|---|---|
| 27 October 2026 | 13G | BlackRock, Inc. and 1 other | 338,133 | 5.0% | 30 September 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 12 August 2026 | 13G/A | Saturn V Capital Management LP and 3 others | 313,384 | 4.7% | 30 June 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 12 August 2026 | 13G/A | Adage Capital Management, L.P. and 5 others | 324,195 | 4.8% | 30 June 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 15 May 2026 | 13G | Saturn V Capital Management LP and 3 others | 345,626 | 5.2% | 5 January 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 13 May 2026 | 13G/A | Adage Capital Management, L.P. and 5 others | 424,195 | 6.2% | 31 March 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 17 February 2026 | 13G/A | RA Capital Management, L.P. and 7 others | 667,632 | 9.9% | 31 December 2025 | passive, under 20% (13d-1(c)) | EDGAR |
| 6 February 2026 | 13G/A | AstraZeneca PLC and 3 others | 522,667 | 7.8% | 31 December 2025 | passive, under 20% (13d-1(c)) | EDGAR |
| 30 January 2026 | 13D/A | Tactic Pharma LLC and 2 others | 307,370 | 4.5% | 28 January 2026 | EDGAR | |
| 14 November 2025 | 13G/A | Janus Henderson Group PLC and 3 others | 1.3 million | 19.5% | 30 September 2025 | passive, institutional (13d-1(b)) | EDGAR |
| 14 November 2025 | 13G/A | RA Capital Management, L.P. and 7 others | 742,861 | 9.9% | 30 September 2025 | passive, under 20% (13d-1(c)) | EDGAR |
Read more
Amendments (/A) report a change, including an exit to zero. Holding and percentage are as the filer stated them on the cover page; the purpose is the filer's own words, cut short. 13D and 13GFails to deliver
| Settlement date | Shares failed | Price | File |
|---|---|---|---|
| 3 September 2026 | 1,507 | $116.28 | SEC |
| 1 September 2026 | 446 | $111.93 | SEC |
| 24 August 2026 | 310 | $107.72 | SEC |
| 18 August 2026 | 407 | $116.49 | SEC |
| 17 August 2026 | 176 | $113.04 | SEC |